What's New and What to Do: Critical Updates to Regulatory Requirements for Injectable Packaging

In the fast-paced world of pharmaceuticals, it is crucial for injectable drug developers to stay informed about the ever-changing requirements set forth by regulatory authorities. These updates not only ensure enhanced patient safety, but also help maintain strict adherence to standards when prescribing or administering injectable medications. In this webinar, industry experts will educate the audience about the latest updates to USP and EU GMP requirements, and will explain how to confidently navigate the complexities of injectable drug regulations.

Key Learning Objectives:

• Gain valuable insights into the latest regulatory updates, particularly the upcoming modifications to USP 382
• Discover how pharmaceutical packaging suppliers are partnering with customers to provide comprehensive support in navigating the intricate regulatory environment surrounding injectable medications
• Discover effective strategies to proactively anticipate and manage future regulatory changes, minimizing potential risks

Who Should Attend:

• Quality/regulatory personnel in parenteral drug delivery
• Formulation scientists and packaging engineers
• Device development engineers and managers
• Technical functions surrounding drug delivery systems
• Extractable and leachable experts
• Procurement professionals

Tabassam Sharif, an experienced Manager of Regulatory Affairs at Datwyler since 2018, brings a wealth of knowledge and expertise to the pharmaceutical industry. With a Master's degree in Natural Sciences and 15 years of experience in Regulatory Affairs, Tabassam is well-versed in the intricacies of navigating drug regulations. In his current role, he holds global responsibility for submitting and updating Drug Master Files with health authorities, providing invaluable support to pharmaceutical companies seeking regulatory approvals. Additionally, Tabassam actively contributes to standardization efforts as a member of various esteemed groups, including the Ph. Eur. experts Group 16, ISO Technical Committee 76 / WG4, and the PDA Task Force on TR 73-2. His extensive involvement in these initiatives further showcases his commitment to staying at the forefront of regulatory advancements.

Speaker's Email: tabassam.sharif@datwyler.com 
Speaker's LinkedIn: Tabassam Sharif